The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Siris, S. G.
* Articles by Casey, E.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Siris, S. G.
* Articles by Casey, E.

Am J Psychiatry 1988; 145:1532-1537
Copyright © 1988 by American Psychiatric Association


BRIEF REPORTS

Postpsychotic depression and negative symptoms: an investigation of syndromal overlap

SG Siris, F Adan, M Cohen, J Mandeli, A Aronson and E Casey
Mount Sinai School of Medicine, City University of New York.

The authors studied 46 patients with the operationally defined syndrome of postpsychotic depression following episodes of schizophrenia or schizoaffective disorder. Half of these patients were also found to satisfy criteria for negative symptoms. The patients with negative symptoms were rated as more severely ill on global measures, but there was only limited evidence that they were more depressed. Nevertheless, in a randomized double-blind trial of imipramine versus placebo as an adjunct to the fluphenazine decanoate and benztropine regimens of the patients with negative symptoms, the patients who received imipramine seemed to show more improvement.


This article has been cited by other articles:


Home page
Schizophr BullHome page
P. F. Buckley, B. J. Miller, D. S. Lehrer, and D. J. Castle
Psychiatric Comorbidities and Schizophrenia
Schizophr Bull, March 1, 2009; 35(2): 383 - 402.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
E. Chemerinski, C. Bowie, H. Anderson, and P. D. Harvey
Depression in Schizophrenia: Methodological Artifact or Distinct Feature of the Illness?
J Neuropsychiatry Clin Neurosci, November 1, 2008; 20(4): 431 - 440.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
S. G. Siris
Suicide and schizophrenia
J Psychopharmacol, March 1, 2001; 15(2): 127 - 135.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
S. G. Siris, P. C. Bermanzohn, S. E. Mason, and M. A. Shuwall
Maintenance Imipramine Therapy for Secondary Depression in Schizophrenia: A Controlled Trial
Arch Gen Psychiatry, February 1, 1994; 51(2): 109 - 115.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
D. P. van Kammen, J. Peters, J. Yao, W. B. van Kammen, T. Neylan, D. Shaw, and M. Linnoila
Norepinephrine in Acute Exacerbations of Chronic Schizophrenia: Negative Symptoms Revisited
Arch Gen Psychiatry, February 1, 1990; 47(2): 161 - 168.
[Abstract] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1988 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org